Use of cookies
Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy
Cardiovascular diseases - especially CHD such as ischaemic heart disease and heart attacks - are the most common cause of death in Germany. People with diabetes have an increased risk of developing cardiovascular disease. The assessment of cardiovascular risk in people with diabetes is a component of optimal treatment and is therefore recommended by the NVL on type 2 diabetes therapy for the prevention of cardiovascular disease in people with diabetes (BÄK et al. 2013).
Indikatoren_ScreenreaderHinweis_Datentabelle
Indikatoren_ScreenreaderHinweis_Datentabelle
Indikatoren_ScreenreaderHinweis_Datentabelle
Indikatoren_ScreenreaderHinweis_Datentabelle
Indikatoren_ScreenreaderHinweis_Datentabelle
In 2010, 45- to 79-year-olds with type 2 diabetes had on average a 21.1% absolute 10-year risk of developing CHD (women: 16.0%; men: 26.2%). The risk for 65- to 79-year-olds is about twice as high (27.6%) as for 45- to 64-year-olds (13.2%). In 2010, a higher risk was observed among people in the lower education group than among those in the middle and higher education group (23.5% vs 16.9%); this can be attributed to a smaller reduction in the risk in the lower education group since 1998. No significant differences in the risk of developing CHD were found for either survey time between the western and eastern part of Germany. The mean 10-year risk has decreased among women and men since 1998. A decrease in the risk can also be observed when stratified by age, education and region.
In Germany, 45- to 79-years olds with type 2 diabetes had a significantly lower 10-year risk of developing CHD in 2010 than in 1998, regardless of sex, age, region and education. Improvements in the quality of care for people with type 2 diabetes in Germany may have contributed to this positive development (Du et al. 2015, Heidemann et al. 2019). In particular, antidiabetic, antihypertensive and lipid-lowering medications were increasingly used for intensive therapy in clinical practice during this period. People with type 2 diabetes showed improvements in the risk profile with regard to HbA1c (long-term blood glucose value), blood pressure and blood lipids, which are the key components in the calculation of the risk score.